EU accepts Sanofi concessions, closes flu vaccine antitrust probe

The European Commission accepted Sanofi's commitments to resolve an antitrust investigation into its flu vaccine marketing practices, ending the probe without a fine. The concessions likely involve behavioral remedies to address competition concerns. This removes regulatory overhang for Sanofi but has limited market-wide impact.